# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: David Hume (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN012-SYN-TD
- Date: 1775-06-01
- Fictional facility: St. Posthumous Health Center
- Fictional author: Fiona Gallacher, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Review of colonoscopy, biopsy, and staging results. **S**

## History of present illness

Mr. Hume returns three weeks after presenting with looser stools, dark blood, tiredness, and iron deficiency anemia. Colonoscopy thirteen days ago reached the cecum and found a 4 cm ulcerated mass at 28 cm in the sigmoid colon, which was biopsied and tattooed; there were no other lesions. The biopsy shows moderately differentiated adenocarcinoma with intact mismatch-repair proteins. The staging CT eleven days ago showed two small pericolic lymph nodes, clear lungs, and one 9 mm indeterminate lesion in the liver. He still has two or three loose stools a day with dark blood on some days, and he tires on hills. His weight is down a further 0.8 kg. He saw Dr. Mehta of medical oncology this morning and has a colorectal surgery appointment this week. He took the news calmly and asked for the facts plainly; he wants to keep working on his books. **S**

| Element | Detail |
|---|---|
| Interval change | Diagnosis confirmed by biopsy; staging CT done |
| Bowel symptoms | Two or three loose stools a day; dark blood on some days |
| Weight | Down 0.8 kg in three weeks |
| Function | Tires on hills; working at his desk each morning |
| Coordination | Medical oncology seen today; colorectal surgery this week |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tiredness; weight loss; no fever or night sweats |
| Gastrointestinal | Positive | Loose stools with dark blood on some days; no abdominal pain, distension, or vomiting |
| Cardiovascular | Negative | No chest pain or palpitations at rest |
| Respiratory | Negative | Breathless only on steep hills |
| Genitourinary | Negative | No urinary symptoms |

5 systems reviewed. **S**

## Current medications

- Ferric carboxymaltose 750 mg intravenous infusion, two doses one week apart **S**

## Allergies

- No known allergy **S**

## Objective

BP 130/78 mmHg; pulse 88 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 87.2 kg; BMI 27.5 kg/m². All vital signs are synthetic.

CEA: 6.4 ng/mL (high); Hemoglobin: 10.3 g/dL (low); ALT: 24 U/L; AST: 21 U/L; Alkaline phosphatase: 88 U/L; Total bilirubin: 0.6 mg/dL. All results are synthetic.

## Change since baseline

- Hemoglobin: 10.6 g/dL (low) at baseline, 10.3 g/dL (low) at this visit **S**
- ALT: 22 U/L at baseline, 24 U/L at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Comfortable, pale |
| Eyes | Conjunctival pallor |
| Abdomen | Soft, non-tender; no palpable mass; liver not enlarged; no ascites |
| Lymph nodes | No supraclavicular or inguinal nodes |
| Cardiovascular | Regular rhythm, heart rate 88; soft flow murmur |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Adenocarcinoma of the sigmoid colon, clinical stage T3 N1, metastasis not yet excluded** (C18.7). Biopsy-proven, mismatch-repair proficient. CEA 6.4 ng/mL is raised and will be the baseline for surveillance. Liver tests are normal. The 9 mm liver lesion is too small to characterize on CT and must be clarified before surgery, because a metastasis would change the plan. **S**
   - MRI of the liver with contrast in three days, as Dr. Mehta advised.
   - Colorectal surgery appointment this week for laparoscopic sigmoid colectomy if the liver lesion is benign.
   - Plan adjuvant treatment after the surgical pathology is known.
2. **Iron deficiency anemia from tumor blood loss** (D50.0). Hemoglobin 10.3 g/dL with ferritin 9 ng/mL at presentation. Surgery is about two weeks away, too soon for oral iron to work. **S**
   - Ferric carboxymaltose 750 mg intravenously today and again in one week.
   - Blood count and ferritin six to eight weeks after the infusion, at the postoperative visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | CEA, preoperative baseline | Once before resection | Completed today | 6.4 ng/mL, raised |
| Laboratory | Liver tests at staging (ALT, AST, alkaline phosphatase, bilirubin) | At staging | Completed today | All normal |
| Laboratory | Hemoglobin before intravenous iron | Before treatment | Completed today | 10.3 g/dL |
| Imaging | CT of the chest, abdomen, and pelvis | At staging | Up to date | Done eleven days ago: two pericolic nodes up to 7 mm, clear lungs, one indeterminate 9 mm liver lesion |
| Imaging | MRI of the liver | When CT shows an indeterminate liver lesion | Ordered | Booked in three days |
| Examination | Complete colonoscopy before resection | At diagnosis | Up to date | Reached the cecum thirteen days ago; no other lesions, so the first surveillance colonoscopy will be due one year after resection |
| Laboratory | Mismatch-repair testing of the tumor | At diagnosis, for every colorectal cancer | Up to date | MLH1, PMS2, MSH2, and MSH6 intact on the biopsy (mismatch-repair proficient) |
| Referral | Medical oncology | At diagnosis | Completed today | Seen this morning; recommendations in the consultation note |
| Referral | Colorectal surgery | At diagnosis | Referred | Appointment this week |
| Medication safety | Intravenous iron infusion | Each dose | Completed today | First 750 mg dose given with 30 minutes of observation; no reaction |
| Laboratory | Blood count and ferritin after intravenous iron | 6 to 8 weeks after infusion | Due | At the postoperative visit |
| Survey | Distress and depression screen (PHQ-2) | At each follow-up visit | Deferred | Not done today, the visit at which the diagnosis and plan were discussed, a deviation from the CMID schedule. He appeared composed and asked for plain facts; screening is added to the postoperative visit |

## Goal progress

- Complete diagnosis, staging, and curative resection within six weeks of presentation. In progress; target 1775-07-13. **S**
- Replete iron stores before surgery and recover hemoglobin by the postoperative review. In progress; target 1775-07-13. **S**
- Complete three months of adjuvant CAPOX with neuropathy no worse than grade 1. In progress; target 1775-10-19. **S**
- Start survivorship surveillance with a written survivorship care plan. In progress; target 1775-10-19. **S**

## Medication changes

- Started: Ferric carboxymaltose 750 mg intravenous infusion, two doses one week apart **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Colon Cancer, Version 4.2025 (2025), National Comprehensive Cancer Network
- AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia (2020), American Gastroenterological Association
- CMID: Clinical Monitoring Intelligence Database, colorectal cancer and anemia monographs (2026), Aether Forge

## Follow-up

- MRI of the liver in three days. Second iron infusion in one week. Colorectal surgery this week. Primary care review about four weeks after surgery. **S**
- Next scheduled visit 1775-07-13: review four weeks after laparoscopic sigmoid colectomy, before adjuvant chemotherapy. **S**
